Pulmonx Corporation
LUNG
$1.58
-$0.01-0.63%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 1.00% | -5.08% | 5.13% | 5.07% | 5.37% |
Total Depreciation and Amortization | -25.25% | -34.28% | 2.44% | -202.17% | -2.20% |
Total Amortization of Deferred Charges | -99.25% | -31.25% | -15.38% | 6,138.46% | 14,325.00% |
Total Other Non-Cash Items | 2.83% | -6.90% | -3.78% | -17.14% | -4.54% |
Change in Net Operating Assets | 255.72% | -3.33% | 286.97% | 180.80% | -11.29% |
Cash from Operations | 32.27% | -12.10% | 20.35% | 16.04% | 26.88% |
Capital Expenditure | 89.55% | 33.26% | 44.50% | 15.45% | -768.52% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 1,608.20% | 908.07% | 654.91% | 384.58% | 51.78% |
Cash from Investing | 755.21% | 750.70% | 610.60% | 583.99% | -2.71% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -4.35% | -- | -4.26% | -- | 2.13% |
Issuance of Common Stock | 16.67% | -23.15% | 73.44% | -19.61% | -82.73% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -204.55% | -23.15% | 264.71% | -19.61% | -123.91% |
Foreign Exchange rate Adjustments | -1,167.39% | -318.75% | 191.90% | -158.91% | -319.05% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 113.68% | 127.26% | 166.61% | 97.80% | 22.33% |